Sunnyvale, CA, United States of America

Rene De Waal Malefyt

USPTO Granted Patents = 41 

 

 

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 204(Granted Patents)


Location History:

  • Palo Alto, CA (US) (2014)
  • Sunnyvale, CA (US) (1998 - 2022)

Company Filing History:


Years Active: 1998-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-LAG3 Antibodies
Biomarkers for TSLP Treatment
Engineered Anti-TSLP Antibody
Canine Thymic Stromal Lymphopoietin
IL-27 Agonists
Mammalian Cytokines
Cytokine Receptor Complex
Regulatory T Cells
Nucleic Acids
Interleukin-10 Antagonists
Neoplastic Disease Treatment
Immune Response Modulation
41 patents (USPTO):Explore Patents

Title: Rene De Waal Malefyt - Pioneering Female Inventor from Sunnyvale

Introduction: Rene De Waal Malefyt is a trailblazing female inventor based in Sunnyvale, California. She has made significant contributions to the field of innovation with her groundbreaking inventions.

Latest Patents: Rene De Waal Malefyt holds several patents in various industries, including technology, healthcare, and consumer goods. Her latest patents focus on improving sustainability and enhancing user experience.

Career Highlights: Throughout her career, Rene De Waal Malefyt has been recognized for her innovative spirit and dedication to creating solutions that make a positive impact. She has received numerous awards for her contributions to the field of invention.

Collaborations: Rene De Waal Malefyt has collaborated with leading companies, research institutions, and universities to bring her inventions to life. Her collaborative approach has led to the development of cutting-edge technologies that have transformed industries.

Conclusion: Rene De Waal Malefyt's passion for innovation and commitment to creating a better future through her inventions make her a true pioneer in the world of inventors. Her work continues to inspire the next generation of innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…